These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 34495412)

  • 21. EANM guideline on quality risk management for radiopharmaceuticals.
    Gillings N; Hjelstuen O; Behe M; Decristoforo C; Elsinga PH; Ferrari V; Kiss OC; Kolenc P; Koziorowski J; Laverman P; Mindt TL; Ocak M; Patt M; Todde S; Walte A
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3353-3364. PubMed ID: 35385986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimodality molecular imaging--from target description to clinical studies.
    Schober O; Rahbar K; Riemann B
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):302-14. PubMed ID: 19130054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemistry and radiochemistry of As, Re and Rh isotopes relevant to radiopharmaceutical applications: high specific activity radionuclides for imaging and treatment.
    Feng Y; Phelps TE; Carroll V; Gallazzi F; Sieckman G; Hoffman TJ; Barnes CL; Ketring AR; Hennkens HM; Jurisson SS
    Dalton Trans; 2017 Oct; 46(42):14677-14690. PubMed ID: 28951905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Consensus nomenclature rules for radiopharmaceutical chemistry - Setting the record straight.
    Coenen HH; Gee AD; Adam M; Antoni G; Cutler CS; Fujibayashi Y; Jeong JM; Mach RH; Mindt TL; Pike VW; Windhorst AD
    Nucl Med Biol; 2017 Dec; 55():v-xi. PubMed ID: 29074076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Quality guidelines for radiopharmacy: Development of a risk-assessment tool].
    Hosselet C; Peyronnet D; Lamballais M; Smadja C; Verrey AS; Tyranowicz S; Galvez D; Joyes P; Danguy des Deserts L; Félice K; Lancelot S
    Ann Pharm Fr; 2021 Sep; 79(5):572-581. PubMed ID: 33524336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microfluidics in radiopharmaceutical chemistry.
    Pascali G; Watts P; Salvadori PA
    Nucl Med Biol; 2013 Aug; 40(6):776-87. PubMed ID: 23684316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ARRONAX Cyclotron: Setting up of In-House Hospital Radiopharmacy.
    Vidal A; Bourdeau C; Frindel M; Garcia T; Haddad F; Faivre-Chauvet A; Bourgeois M
    Biomed Res Int; 2020; 2020():1572841. PubMed ID: 32566657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bulk Scale Formulation of Therapeutic Doses of Clinical Grade Ready-to-Use
    Mathur A; Prashant V; Sakhare N; Chakraborty S; Vimalnath KV; Mohan RK; Arjun C; Karkhanis B; Seshan R; Basu S; Korde A; Banerjee S; Dash A; Sachdev SS
    Cancer Biother Radiopharm; 2017 Sep; 32(7):266-273. PubMed ID: 28910148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 68Ga-PET radiopharmacy: A generator-based alternative to 18F-radiopharmacy.
    Maecke HR; André JP
    Ernst Schering Res Found Workshop; 2007; (62):215-42. PubMed ID: 17172157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classics in Neuroimaging: Imaging the Cholinergic System with Positron Emission Tomography.
    Sowa Dumond AR; Gross HK; Bohnen NI; Kanel P; Müller MLTM; Koeppe RA; Kilbourn MR; Scott PJH
    ACS Chem Neurosci; 2021 May; 12(9):1472-1479. PubMed ID: 33890459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Erratum: Publisher Correction to
    BioMed Central
    EJNMMI Radiopharm Chem; 2018 Dec; 3():13. PubMed ID: 31329807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiochemistry, pre-clinical studies and first clinical investigation of 90Y-labeled hydroxyapatite (HA) particles prepared utilizing 90Y produced by (n,γ) route.
    Vimalnath KV; Chakraborty S; Rajeswari A; Sarma HD; Nuwad J; Pandey U; Kamaleshwaran K; Shinto A; Dash A
    Nucl Med Biol; 2015 May; 42(5):455-464. PubMed ID: 25659856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation of Rhenium-188-Lipiodol Using Freeze-Dried Kits for Transarterial Radioembolization: An Overview and Experience in a Hospital Radiopharmacy.
    Radhakrishnan ER; Chirayil V; Pandiyan A; Subramanian S; Mallia MB; Kamaleshwaran KK; Shinto A
    Cancer Biother Radiopharm; 2022 Feb; 37(1):63-70. PubMed ID: 34101501
    [No Abstract]   [Full Text] [Related]  

  • 34. On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversion.
    Herth MM; Ametamey S; Antuganov D; Bauman A; Berndt M; Brooks AF; Bormans G; Choe YS; Gillings N; Häfeli UO; James ML; Kopka K; Kramer V; Krasikova R; Madsen J; Mu L; Neumaier B; Piel M; Rösch F; Ross T; Schibli R; Scott PJH; Shalgunov V; Vasdev N; Wadsak W; Zeglis BM
    Nucl Med Biol; 2021 Feb; 93():19-21. PubMed ID: 33232876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacology and pharmacokinetics of stereoisomers in radiopharmacy.
    Cohen Y; Besnard M
    Acta Radiol Suppl; 1991; 376():36-9. PubMed ID: 1666775
    [No Abstract]   [Full Text] [Related]  

  • 36. Positron emission tomography radiochemistry.
    Mason NS; Mathis CA
    Neuroimaging Clin N Am; 2003 Nov; 13(4):671-87. PubMed ID: 15024954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of COVID-19 on nuclear medicine and radiopharmacy activities: A global survey.
    Al-Saeedi F; Rajendran P; Tipre D; Aladwani H; Alenezi S; Alqabandi M; Alkhamis A; Redha A; Mohammad A; Ahmad F; Abdulnabi Y; Alfadhly A; Alrasheedi D
    Sci Rep; 2023 Jun; 13(1):10489. PubMed ID: 37380735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective of ⁶⁸Ga-radiopharmaceutical development.
    Velikyan I
    Theranostics; 2013 Dec; 4(1):47-80. PubMed ID: 24396515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of the failure modes and effects analysis in a Hospital Radiopharmacy Unit.
    Romero-Zayas I; Campos Añón F; Santos Virosta M; Cordón Del Pozo J; Santos Montero C; Niñerola Baizán A; Fuster D
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(5):300-310. PubMed ID: 35668016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals: a concise overview and practical guidance for a risk-based approach.
    Lange R; ter Heine R; Decristoforo C; Peñuelas I; Elsinga PH; van der Westerlaken MM; Hendrikse NH
    Nucl Med Commun; 2015 May; 36(5):414-22. PubMed ID: 25646703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.